TY  - JOUR
AU  - Gamaza-Chulián, Sergio
AU  - Díaz-Retamino, Enrique
AU  - González-Testón, Fátima
AU  - Gaitero, José Carlos
AU  - Castillo, María José
AU  - Alfaro, Raquel
AU  - Rodríguez, Elías
AU  - González-Caballero, Eva
AU  - Martín-Santana, Antonio
PY  - 2021
DO  - 10.1186/s12872-021-02250-9
UR  - https://hdl.handle.net/10668/25085
T2  - BMC cardiovascular disorders
AB  - Sodium-glucose cotransporter 2 inhibitors (SGLT2i) lower cardiovascular events in type 2 diabetes mellitus (T2DM) patients, although the mechanisms underlying these benefits are not clearly understood. Our aim was to study the effects of SGLT2i on...
LA  - en
KW  - Cardiac remodelling
KW  - Diabetes mellitus
KW  - SGLT2 inhibitors
KW  - Speckle tracking echocardiography
KW  - Aged
KW  - Biomarkers
KW  - Blood Glucose
KW  - Diabetes Mellitus, Type 2
KW  - Echocardiography, Doppler
KW  - Female
KW  - Glycated Hemoglobin
KW  - Heart Failure
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Prospective Studies
KW  - Recovery of Function
KW  - Sodium-Glucose Transporter 2 Inhibitors
KW  - Time Factors
KW  - Treatment Outcome
KW  - Ventricular Function, Left
KW  - Ventricular Remodeling
TI  - Effect of sodium-glucose cotransporter 2 (SGLT2) inhibitors on left ventricular remodelling and longitudinal strain: a prospective observational study.
TY  - research article
VL  - 21
ER  -